Researchers
Name (Institute) |
|
||||
|---|---|---|---|---|---|
| Specialty | • Pharmacoepidemiology
• Pharmacovigilance • Pharmacoeconomy • Real-world data and Real-world evidence • Health Technology Assessment • Therapeutic Risk Management |
||||
| Science Interest (Past) |
• type 2 diabetes mellitus:
• Effectiveness of Bevacizumab in metastatic colorectal cancer • Cost Effectiveness Analysis of Rivaroxaban • Antihypertensive drug use • Economic burden of dengue in Indonesia. • Rationing for medicines by health care providers • Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals an application on improving tender decision making in Indonesia. |
||||
| Science Interest (Current) |
• Budget Impact Analysis Of Sacubitril Valsartan for Heart Failure Treatment in Indonesia.
• Drug Utilization Review as an Evaluation of the Implementation of National Formulary during the Implementation of the National Health Insurance (JKN) in Indonesian Hospital, period of 2019. Indonesian Ministry of Health, Jakarta, 2020. • “The affected factors of loss to follow up (LFU) among HIV patients with antiretroviral therapy (ART) |
||||
| Science Interest (Future) |
Research and publication on tuberculosis
Research and publication related to multi-criteria decision analysis (MCDA) for drug assessment Research and publication on the use of sacubitril/valsartan |
||||
| Website / Contact | - |
